AbbVie’s Allergan Cuts Over 200 Staff After Marketing Campaign Failure
SOURCENews reportView the filing ↗
What we know
Based on news reporting.
Summary
AbbVie Inc.'s subsidiary, Allergan, has laid off over 200 employees following a failed marketing campaign. The decision comes as part of a restructuring effort to realign the company's focus and resources. The layoffs are indicative of the challenges faced by Allergan in effectively promoting its products. While specific locations and departments affected were not disclosed, the cuts reflect a significant adjustment in workforce strategy. This move is part of AbbVie's broader efforts to streamline operations and enhance efficiency in a competitive market.
AbbVie Inc. cut 200 jobs as of May 28, 2025.
That is roughly 0.4% of the 50,000 people AbbVie Inc. employs.
LayoffTalk has tracked 9 layoff events at AbbVie Inc. since November 2022, including 243 jobs documented in official WARN filings, with 6 additional events known from news reporting.
Comments (0)
Anonymous by default. Be kind — people reading this may be going through it right now.
No comments yet. Be the first to share your thoughts.
Affected by this?
Share your story anonymously — it helps others reading this feel less alone.
Share your story →More layoffs at AbbVie Inc.
Recent tracked events at this company.